The Administration for Strategic Preparedness and Response has partnered with SLI Medical to ship 41,000 cases of IV fluids to the U.S. to help mitigate an ongoing shortage exacerbated by disruptions at a Baxter plant in North Carolina.
Category: Supply Chain
Baxter recovery efforts: 3 IV shortage updates
Baxter continues to restore manufacturing operations at its North Cove, N.C., site, revealing the production on several key product lines has resumed, according to a Dec. 5 news release from the company.
Supply chain challenges in 2025: 5 things to know
The healthcare industry is still grappling with supply disruptions, and experts predict these challenges will persist in 2025, according to the American Hospital Association’s 2025 Environmental Scan report.
Shortage of IV containers expected to last until March: FDA
The FDA announced that IV fluid containers of all sizes have been added to its medical device shortages list, with the shortage expected to persist through March 2025.
The men driving Trump's supply chain policies
Throughout his campaign and time as President-elect, Donald Trump has issued several proposals regarding the U.S. supply chain, from plans to raise tariffs up to 100% for certain countries to a complete restructuring of the global supply chain.
How the last Trump tariffs impacted the supply chain
President-elect Donald Trump plans to implement new tariffs against Canada, Mexico and China, three of America’s leading trading partners, in a post on social media network Truth Social.
HHS invests $44M in medical supply chain
The Administration for Strategic Preparedness and Response, an HHS agency, is providing $44 million to bolster the U.S. public health supply chain.
Baxter moves closer to 100% allocation levels for IV products
Baxter has implemented new allocation levels for several U.S. IV product groups, effective Nov. 26, as part of recovery efforts at its North Carolina manufacturing site.
Trump tariff plan would affect 75% of U.S. medical devices: 4 notes
President-elect Donald Trump’s plan to impose tariffs on imported goods is expected to affect the prices of approximately 75% of medical devices marketed in the U.S., according to consulting firm GlobalData’s Medsource Database, Medical Device Network …
FDA looks to improve communication on high-risk medical device recalls
The FDA’s Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
